Biofrontera Inc. Other Operating Activities, Cash Flow Statement
Biofrontera Inc. (BFRI) reported Other Operating Activities, Cash Flow Statement of $428.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2023-11-09
- Biofrontera Inc. other operating activities, cash flow statement for the quarter ending 2023-09-30 was $135.00K.
- Biofrontera Inc. other operating activities, cash flow statement for the quarter ending 2023-06-30 was $139.00K.
- Biofrontera Inc. other operating activities, cash flow statement for the quarter ending 2023-03-31 was $154.00K.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 12 month |
|---|---|---|---|---|
| 2023-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $274.00K derived: sum of 2 quarters · filed 2023-11-09 | $428.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $293.00K 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | $154.00K 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $781.00K 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |